Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AF34134 single ascending dose and food interaction study in healthy volunteers
NL-OMON37707Phase 1Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lu AF34134 in Parkinson's disease (PD) (3 arms), sponsored by Lundbeck. Primary endpoint: Safety and tolerability. Started Nov 2011; status: active, not recruiting.
02
Drugs
Lu AF34134
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON37707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37707.